{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:24:43Z","timestamp":1790886283819,"version":"4.1.0"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"17","license":[{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"the Clinical Medical Technology Demonstration Base for Cancer Precision Radiotherapy in Hunan Province","award":["2020SK4021"],"award-info":[{"award-number":["2020SK4021"]}]},{"name":"The science and technology innovation program of Hunan Province","award":["2017SK51302"],"award-info":[{"award-number":["2017SK51302"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4,25]]},"abstract":"<jats:p>\n                    This study evaluates the dosimetric benefits of off-line adaptive radiotherapy (ART) planning during radiotherapy for locally advanced cervical cancer. Forty-four patients in our hospital were included. The patients were monitored by cone-beam CT (CBCT), and the secondary CT scanning was performed timely. The ART2 planning was performed based on tumor regression and compared with the initial radiotherapy planning (ART1). The mean time of the secondary CT scanning was the thirteen fractions, and the mean gross tumor volume (GTV) decreased by 23.3%. The ART2 compared with the ART1 planning, significantly reduced the mean dose of PGTV (defined as the GTV with 5\u2009mm expansion all directions)-D\n                    <jats:sub>2%<\/jats:sub>\n                    , V\n                    <jats:sub>110<\/jats:sub>\n                    , and PTV-V\n                    <jats:sub>110<\/jats:sub>\n                    by 1.9 Gy, 9.2%, and 3.4%, whereas there was no significant difference in tumor target D\n                    <jats:sub>98%<\/jats:sub>\n                    , D\n                    <jats:sub>50%<\/jats:sub>\n                    , and V\n                    <jats:sub>100<\/jats:sub>\n                    between the two groups. The HI of PGTV and planning target volume (PTV) was significantly lower in the ART2 planning. For the comparison of OARs dosimetric parameters, the ART2 planning was significantly decreased the mean dose of rectum-D\n                    <jats:sub>mean<\/jats:sub>\n                    (2 Gy), D\n                    <jats:sub>1cc<\/jats:sub>\n                    (0.6 Gy), V\n                    <jats:sub>30<\/jats:sub>\n                    (7.3%) and V\n                    <jats:sub>40<\/jats:sub>\n                    (5.9%), bladder-D\n                    <jats:sub>1cc<\/jats:sub>\n                    (1.1 Gy), left femoral head-D\n                    <jats:sub>mean<\/jats:sub>\n                    (1.2 Gy), V\n                    <jats:sub>40<\/jats:sub>\n                    (1.3%) and right femoral head-D\n                    <jats:sub>mean<\/jats:sub>\n                    (1.3 Gy), but significantly increased the small intestinal-V\n                    <jats:sub>30<\/jats:sub>\n                    (2.5%). Other OARs dosimetric parameters were similar between two plannings. The Off-line ART planning can adapt for the changes in the target volume, and further decrease the target volume hotspot area\/dose and OARs irradiation dose in locally advanced cervical cancer patients. And the clinical benefit of ART still needs to be verified in clinical trials.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000042280","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T23:00:21Z","timestamp":1745881221000},"page":"e42280","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Dosimetric evaluation of image-guided adaptive radiotherapy for locally advanced cervical cancer"],"prefix":"10.1097","volume":"104","author":[{"given":"Wei","family":"Tian","sequence":"first","affiliation":[{"name":"Department of Oncology, Changde Hospital, Xiangya School of Medicine, Central South University (The First People\u2019s Hospital of Changde City), Changde, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangfeng","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Oncology, Changde Hospital, Xiangya School of Medicine, Central South University (The First People\u2019s Hospital of Changde City), Changde, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pixiao","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Oncology, Changde Hospital, Xiangya School of Medicine, Central South University (The First People\u2019s Hospital of Changde City), Changde, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Oncology, Changde Hospital, Xiangya School of Medicine, Central South University (The First People\u2019s Hospital of Changde City), Changde, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Oncology, Changde Hospital, Xiangya School of Medicine, Central South University (The First People\u2019s Hospital of Changde City), Changde, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqiang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Oncology, Changde Hospital, Xiangya School of Medicine, Central South University (The First People\u2019s Hospital of Changde City), Changde, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Oncology, Changde Hospital, Xiangya School of Medicine, Central South University (The First People\u2019s Hospital of Changde City), Changde, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongming","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Changde Hospital, Xiangya School of Medicine, Central South University (The First People\u2019s Hospital of Changde City), Changde, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Oncology, Changde Hospital, Xiangya School of Medicine, Central South University (The First People\u2019s Hospital of Changde City), Changde, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Oncology, Changde Hospital, Xiangya School of Medicine, Central South University (The First People\u2019s Hospital of Changde City), Changde, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4716-1062","authenticated-orcid":false,"given":"Zemin","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Oncology, Changde Hospital, Xiangya School of Medicine, Central South University (The First People\u2019s Hospital of Changde City), Changde, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250904","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0140-6736(18)32470-X","article-title":"Cervical cancer.","volume":"393","author":"Cohen","year":"2019","journal-title":"Lancet"},{"key":"R2-20250904","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.clon.2021.06.007","article-title":"Adaptive radiotherapy in the management of cervical cancer: review of strategies and clinical implementation.","volume":"33","author":"Shelley","year":"2021","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"R3-20250904","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.radonc.2021.10.015","article-title":"Pelvic bone marrow sparing radiotherapy for cervical cancer: A systematic review and meta-analysis.","volume":"165","author":"Zhou","year":"2021","journal-title":"Radiother Oncol"},{"key":"R4-20250904","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1136\/ijgc-2022-004230","article-title":"Improvement in radiation techniques for locally advanced cervical cancer during the last two decades.","volume":"33","author":"Sagae","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"R5-20250904","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.zemedi.2017.09.004","article-title":"Image guided adaptive external beam radiation therapy for cervix cancer: Evaluation of a clinically implemented plan-of-the-day technique.","volume":"28","author":"Buschmann","year":"2018","journal-title":"Z Med Phys"},{"key":"R6-20250904","doi-asserted-by":"crossref","first-page":"943","DOI":"10.3109\/0284186X.2016.1156738","article-title":"Adaptive radiotherapy strategies for pelvic tumors \u2013 a systematic review of clinical implementations.","volume":"55","author":"Th\u00f6rnqvist","year":"2016","journal-title":"Acta Oncol"},{"key":"R7-20250904","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ijrobp.2014.06.005","article-title":"Comparison and consensus guidelines for delineation of clinical target volume for CT- and MR-based brachytherapy in locally advanced cervical cancer.","volume":"90","author":"Viswanathan","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R8-20250904","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejmp.2019.01.012","article-title":"Volumetric modulated arc therapy with robust optimization for larynx cancer.","volume":"58","author":"Miura","year":"2019","journal-title":"Phys Med"},{"key":"R9-20250904","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.clon.2013.11.031","article-title":"A systematic review of organ motion and image-guided strategies in external beam radiotherapy for cervical cancer.","volume":"26","author":"Jadon","year":"2014","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"R10-20250904","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1177\/1533034616685942","article-title":"Changes in tumor volumes and spatial locations relative to normal tissues during cervical cancer radiotherapy assessed by cone beam computed tomography.","volume":"16","author":"Chen","year":"2017","journal-title":"Technol Cancer Res Treat"},{"key":"R11-20250904","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijrobp.2005.04.025","article-title":"Conventional, conformal, and intensity-modulated radiation therapy treatment planning of external beam radiotherapy for cervical cancer: the impact of tumor regression.","volume":"64","author":"van de Bunt","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R12-20250904","first-page":"818","article-title":"IMRT for cervical cancer: study of target region regression.","volume":"39","author":"Pang","year":"2012","journal-title":"Cancer Res Prev Treat"},{"key":"R13-20250904","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.rpor.2017.12.005","article-title":"Compliance with bladder protocol during concurrent chemoradiation for cancer of the cervix and its impact on enteritis: a prospective observational study.","volume":"23","author":"Bandanatham","year":"2018","journal-title":"Reports Pract Oncol Radiother"},{"key":"R15-20250904","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.radonc.2008.04.009","article-title":"Online MRI guidance for healthy tissue sparing in patients with cervical cancer: an IMRT planning study.","volume":"88","author":"Kerkhof","year":"2008","journal-title":"Radiother Oncol"},{"key":"R16-20250904","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000484608","article-title":"Volumetric modulated arc therapy versus fixed-field intensity-modulated radiotherapy in radical irradiation for cervical cancer without lymphadenectasis: dosimetric and clinical results.","volume":"41","author":"Guo","year":"2018","journal-title":"Oncol Res Treat"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042280","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T12:04:16Z","timestamp":1756987456000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":15,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000042280","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,25]]}}}